 | • レポートコード：D005-00283 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、糖尿病性網膜症薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。糖尿病性網膜症薬の種類別市場規模（Lucentis、Optina、Iluvien、Betamethazone、Ozurdex、その他）、用途別市場規模（50〜60歳、60〜70歳、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Neurotech Pharmaceuticals、Bayer Healthcare、Roche、Allergan、Regeneron Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・糖尿病性網膜症薬の北米市場（アメリカ、カナダ、メキシコ） ・糖尿病性網膜症薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・糖尿病性網膜症薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・糖尿病性網膜症薬の南米市場（ブラジル、アルゼンチン） ・糖尿病性網膜症薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Lucentis、Optina、Iluvien、Betamethazone、Ozurdex、その他 ・用途別分析：50〜60歳、60〜70歳、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Diabetic Retinopathy Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Diabetic Retinopathy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diabetic Retinopathy Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diabetic Retinopathy Drugs market has been segmented into:
Lucentis
Optina
Iluvien
Betamethazone
Ozurdex
Other
By Application, Diabetic Retinopathy Drugs has been segmented into:
50-60 Years Old
60-70 Years Old
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diabetic Retinopathy Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Diabetic Retinopathy Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diabetic Retinopathy Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Diabetic Retinopathy Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diabetic Retinopathy Drugs Market Share Analysis
Diabetic Retinopathy Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diabetic Retinopathy Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diabetic Retinopathy Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Diabetic Retinopathy Drugs are:
Novartis
Neurotech Pharmaceuticals
Bayer Healthcare
Roche
Allergan
Regeneron Pharmaceuticals
Table of Contents
1 Diabetic Retinopathy Drugs Market Overview
1.1 Product Overview and Scope of Diabetic Retinopathy Drugs
1.2 Classification of Diabetic Retinopathy Drugs by Type
1.2.1 Global Diabetic Retinopathy Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diabetic Retinopathy Drugs Revenue Market Share by Type in 2019
1.2.3 Lucentis
1.2.4 Optina
1.2.5 Iluvien
1.2.6 Betamethazone
1.2.7 Ozurdex
1.2.8 Other
1.3 Global Diabetic Retinopathy Drugs Market by Application
1.3.1 Overview: Global Diabetic Retinopathy Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 50-60 Years Old
1.3.3 60-70 Years Old
1.3.4 Other
1.4 Global Diabetic Retinopathy Drugs Market by Regions
1.4.1 Global Diabetic Retinopathy Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diabetic Retinopathy Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diabetic Retinopathy Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diabetic Retinopathy Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetic Retinopathy Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diabetic Retinopathy Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetic Retinopathy Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Diabetic Retinopathy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neurotech Pharmaceuticals
2.2.1 Neurotech Pharmaceuticals Details
2.2.2 Neurotech Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neurotech Pharmaceuticals SWOT Analysis
2.2.4 Neurotech Pharmaceuticals Product and Services
2.2.5 Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer Healthcare
2.3.1 Bayer Healthcare Details
2.3.2 Bayer Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer Healthcare SWOT Analysis
2.3.4 Bayer Healthcare Product and Services
2.3.5 Bayer Healthcare Diabetic Retinopathy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Diabetic Retinopathy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allergan SWOT Analysis
2.5.4 Allergan Product and Services
2.5.5 Allergan Diabetic Retinopathy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Regeneron Pharmaceuticals
2.6.1 Regeneron Pharmaceuticals Details
2.6.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Regeneron Pharmaceuticals SWOT Analysis
2.6.4 Regeneron Pharmaceuticals Product and Services
2.6.5 Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diabetic Retinopathy Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetic Retinopathy Drugs Players Market Share
3.2.2 Top 10 Diabetic Retinopathy Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diabetic Retinopathy Drugs Revenue and Market Share by Regions
4.2 North America Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
5 North America Diabetic Retinopathy Drugs Revenue by Countries
5.1 North America Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
5.2 USA Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
6 Europe Diabetic Retinopathy Drugs Revenue by Countries
6.1 Europe Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
6.2 Germany Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
6.4 France Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diabetic Retinopathy Drugs Revenue by Countries
7.1 Asia-Pacific Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
7.2 China Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
7.5 India Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
8 South America Diabetic Retinopathy Drugs Revenue by Countries
8.1 South America Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
8.2 Brazil Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diabetic Retinopathy Drugs by Countries
9.1 Middle East & Africa Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diabetic Retinopathy Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Diabetic Retinopathy Drugs Market Forecast by Type (2019-2024)
10.3 Lucentis Revenue Growth Rate (2015-2025)
10.4 Optina Revenue Growth Rate (2015-2025)
10.5 Iluvien Revenue Growth Rate (2015-2025)
10.6 Betamethazone Revenue Growth Rate (2015-2025)
10.7 Ozurdex Revenue Growth Rate (2015-2025)
10.8 Other Revenue Growth Rate (2015-2025)
11 Global Diabetic Retinopathy Drugs Market Segment by Application
11.1 Global Diabetic Retinopathy Drugs Revenue Market Share by Application (2015-2020)
11.2 Diabetic Retinopathy Drugs Market Forecast by Application (2019-2024)
11.3 50-60 Years Old Revenue Growth (2015-2020)
11.4 60-70 Years Old Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Diabetic Retinopathy Drugs Market Size Forecast (2021-2025)
12.1 Global Diabetic Retinopathy Drugs Market Size Forecast (2021-2025)
12.2 Global Diabetic Retinopathy Drugs Market Forecast by Regions (2021-2025)
12.3 North America Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
12.6 South America Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diabetic Retinopathy Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diabetic Retinopathy Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diabetic Retinopathy Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diabetic Retinopathy Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Diabetic Retinopathy Drugs Major Business
Table 7. Novartis Diabetic Retinopathy Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Diabetic Retinopathy Drugs Product and Solutions
Table 10. Novartis Diabetic Retinopathy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Neurotech Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Major Business
Table 13. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Neurotech Pharmaceuticals SWOT Analysis
Table 15. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Product and Solutions
Table 16. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bayer Healthcare Corporate Information, Location and Competitors
Table 18. Bayer Healthcare Diabetic Retinopathy Drugs Major Business
Table 19. Bayer Healthcare Diabetic Retinopathy Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Bayer Healthcare SWOT Analysis
Table 21. Bayer Healthcare Diabetic Retinopathy Drugs Product and Solutions
Table 22. Bayer Healthcare Diabetic Retinopathy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Diabetic Retinopathy Drugs Major Business
Table 25. Roche Diabetic Retinopathy Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Diabetic Retinopathy Drugs Product and Solutions
Table 28. Roche Diabetic Retinopathy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Allergan Corporate Information, Location and Competitors
Table 30. Allergan Diabetic Retinopathy Drugs Major Business
Table 31. Allergan Diabetic Retinopathy Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Allergan SWOT Analysis
Table 33. Allergan Diabetic Retinopathy Drugs Product and Solutions
Table 34. Allergan Diabetic Retinopathy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Regeneron Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Major Business
Table 37. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Regeneron Pharmaceuticals SWOT Analysis
Table 39. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Product and Solutions
Table 40. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Diabetic Retinopathy Drugs Revenue (Million USD) by Players (2015-2020)
Table 42. Global Diabetic Retinopathy Drugs Revenue Share by Players (2015-2020)
Table 43. Global Diabetic Retinopathy Drugs Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Diabetic Retinopathy Drugs Revenue Market Share by Regions (2015-2020)
Table 45. North America Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
Table 46. North America Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Table 47. Europe Diabetic Retinopathy Drugs Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Diabetic Retinopathy Drugs Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Diabetic Retinopathy Drugs Revenue by Countries (2015-2020)
Table 50. South America Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Diabetic Retinopathy Drugs Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Table 53. Global Diabetic Retinopathy Drugs Revenue (Million USD) by Type (2015-2020)
Table 54. Global Diabetic Retinopathy Drugs Revenue Share by Type (2015-2020)
Table 55. Global Diabetic Retinopathy Drugs Revenue Forecast by Type (2021-2025)
Table 56. Global Diabetic Retinopathy Drugs Revenue by Application (2015-2020)
Table 57. Global Diabetic Retinopathy Drugs Revenue Share by Application (2015-2020)
Table 58. Global Diabetic Retinopathy Drugs Revenue Forecast by Application (2021-2025)
Table 59. Global Diabetic Retinopathy Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diabetic Retinopathy Drugs Picture
Figure 2. Global Diabetic Retinopathy Drugs Revenue Market Share by Type in 2019
Figure 3. Lucentis Picture
Figure 4. Optina Picture
Figure 5. Iluvien Picture
Figure 6. Betamethazone Picture
Figure 7. Ozurdex Picture
Figure 8. Other Picture
Figure 9. Diabetic Retinopathy Drugs Revenue Market Share by Application in 2019
Figure 10. 50-60 Years Old Picture
Figure 11. 60-70 Years Old Picture
Figure 12. Other Picture
Figure 13. Global Diabetic Retinopathy Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Diabetic Retinopathy Drugs Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Diabetic Retinopathy Drugs Revenue Market Share in 2019
Figure 22. Global Top 10 Players Diabetic Retinopathy Drugs Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Diabetic Retinopathy Drugs Revenue Market Share by Regions (2015-2020)
Figure 26. Global Diabetic Retinopathy Drugs Revenue Market Share by Regions in 2018
Figure 27. North America Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Europe Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 30. South America Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 32. North America Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. North America Diabetic Retinopathy Drugs Revenue Market Share by Countries in 2019
Figure 34. USA Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Canada Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Europe Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Diabetic Retinopathy Drugs Revenue Market Share by Countries in 2019
Figure 39. Germany Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 40. UK Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 41. France Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Russia Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Italy Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Diabetic Retinopathy Drugs Revenue Market Share by Countries in 2019
Figure 46. China Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Japan Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Korea Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 49. India Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 51. South America Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. South America Diabetic Retinopathy Drugs Revenue Market Share by Countries in 2019
Figure 53. Brazil Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Diabetic Retinopathy Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Diabetic Retinopathy Drugs Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 58. UAE Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Diabetic Retinopathy Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Global Diabetic Retinopathy Drugs Revenue Share by Type (2015-2020)
Figure 62. Global Diabetic Retinopathy Drugs Revenue Share by Type in 2019
Figure 63. Global Diabetic Retinopathy Drugs Market Share Forecast by Type (2021-2025)
Figure 64. Global Lucentis Revenue Growth Rate (2015-2020)
Figure 65. Global Optina Revenue Growth Rate (2015-2020)
Figure 66. Global Iluvien Revenue Growth Rate (2015-2020)
Figure 67. Global Betamethazone Revenue Growth Rate (2015-2020)
Figure 68. Global Ozurdex Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Diabetic Retinopathy Drugs Revenue Share by Application (2015-2020)
Figure 71. Global Diabetic Retinopathy Drugs Revenue Share by Application in 2019
Figure 72. Global Diabetic Retinopathy Drugs Market Share Forecast by Application (2021-2025)
Figure 73. Global 50-60 Years Old Revenue Growth Rate (2015-2020)
Figure 74. Global 60-70 Years Old Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Diabetic Retinopathy Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Diabetic Retinopathy Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Diabetic Retinopathy Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
Figure 80. Europe Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
Figure 82. South America Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Diabetic Retinopathy Drugs Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mil…- 糖尿病性神経障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Diabetic Neuropathy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 5450.8 million by 2025, from USD 4676.5 million in 2019. The Diabet…
- 糖尿病用靴の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetic Shoe market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetic Shoe market report pro…
- 網膜薬及び生物製剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Retinal Drugs and Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinal Drugs and…
- 糖尿病性足潰瘍治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetic Foot Ulcers Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.5% in the forecast period of 2020 to 2025 and will expected to reach USD 5372.6 million by 2025, from USD 4175 million in 2019. The Diabeti…